Randomized parallel-group study to evaluate the impact of cardiac rehabilitation exercise management on improving exercise tolerance among patients with chronic heart disease using a telemetry-based biosignal measurement device
- Conditions
- Chronic heart failure, ischemic heart disease and history of open heart surgerychronic heart disease
- Registration Number
- JPRN-jRCT1042220058
- Lead Sponsor
- Watanabe Takatomo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 170
(1) Patients with a history of chronic heart failure, acute myocardial infarction, angina pectoris, or open heart surgery who are outpatients
(2) Patients who are 20 years of age or older at the time of obtaining consent
(3) Patients who can give written consent to participate in this study
(4) Patients whose %peak VO2 is less than 80%
(1)Patients with difficulty in performing CPX and patients for whom PeakVO2 could not be measured
(2)Patients with heart failure symptoms NYHA3,4
(3)Patients who have difficulty putting on and taking off the wearable device
(4)Patients with dementia and patients with serious psychiatric disorders
(5)Other patients who are judged to be inappropriate as subjects by the principal investigator or investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method